Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy have?
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy has 1,677 citations in the OpenAlex counts ScholarIQ stores.
When was Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy published?
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy has 2007 year in the ScholarIQ index.
What is the open-access status of Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy?
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy has bronze oa status in the ScholarIQ index.
What is the DOI of Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy?
The DOI for Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy is on the source record.
What is the PMID of Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy?
The PMID for Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy is on the source record.
What is the OpenAlex record for Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy?
The OpenAlex for Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy is on the source record.